SS&C Technologies Holdings, Inc. announced its financial results for the first quarter ended March 31, 2022, with GAAP revenue up 5.0% and adjusted revenue up 4.9%. The company reported GAAP earnings per share of $0.64 and adjusted diluted earnings per share of $1.25. SS&C generated $183.5 million in net cash from operating activities and repurchased 2.3 million shares of common stock.
Q1 2022 organic growth was 4.3%, with strong performance from our Alternatives, Intralinks, and Advent business units.
Q1 2022 financial services organic growth, excluding the healthcare business, was 5.9%, which represents 93% of our revenues.
Healthcare revenue declined 15.5% in Q1 2022, but a strong recovery is expected in 2023 with the upcoming launch of DomaniRx.
Repurchased 2.3 million shares of common stock in Q1 2022 at an average price of $75.22 per share for $170.9 million.
SS&C provides guidance for Q2 2022 and FY 2022, including adjusted revenue, adjusted net income, adjusted diluted earnings per share, cash from operating activities, capital expenditures, diluted shares, and effective income tax rate.
Visualization of income flow from segment revenue to net income